T.Man Pharmaceutical PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	392.02	448.39	348.04	307.17	22.19	66.9
Cash & Short-Term Investments	643.39	448.39	348.04	307.17	22.19	66.9
Cash Growth	509.85%	28.83%	13.30%	1284.31%	-66.83%	-
Accounts Receivable	726.9	596.4	577.79	507.27	256.08	206.77
Other Receivables	192.01	17.53	38.75	21.37	23.94	8.08
Receivables	918.91	613.93	616.54	528.64	280.02	214.84
Inventory	676.09	541.45	481.82	357.96	308.9	410.68
Other Current Assets	2.38	470.32	4.99	32.2	4.21	7.25
Total Current Assets	2,241	2,074	1,451	1,226	615.32	699.66
Property, Plant & Equipment	1,155	1,143	1,048	930.41	742.63	724.85
Long-Term Investments	200	-	-	-	-	5
Other Intangible Assets	41.25	33.84	25.69	12.56	1.23	0.27
Long-Term Deferred Tax Assets	42.57	34.25	38.89	40.69	-	-
Other Long-Term Assets	83.59	170.23	63.18	68.24	199.02	171.13
Total Assets	3,763	3,456	2,627	2,278	1,558	1,601
Accounts Payable	682.03	370.1	331.91	333.08	192.3	120.03
Short-Term Debt	890	1,080	503.43	535	614.57	805.17
Current Portion of Long-Term Debt	-	-	33.08	22	16.01	48.34
Current Portion of Leases	5.51	5.66	7.08	4.55	3.01	0.64
Current Income Taxes Payable	25.83	27.53	22.63	110.2	11.34	4.65
Current Unearned Revenue	99.69	72.01	100.29	73.8	-	-
Other Current Liabilities	11.05	20.79	23.98	20.46	59.06	21.2
Total Current Liabilities	1,714	1,576	1,022	1,099	896.29	1,000
Long-Term Debt	-	-	-	33.08	8.33	24.36
Long-Term Leases	64.52	64.95	47.89	44.36	28.28	24.7
Pension & Post-Retirement Benefits	47.74	44.09	35.18	32.13	28.21	22.15
Other Long-Term Liabilities	1.19	0.58	2.39	26.93	25.89	14.86
Total Liabilities	1,828	1,686	1,108	1,236	987	1,086
Common Stock	300	300	246.43	187.3	187.3	50
Additional Paid-In Capital	1,394	1,394	305.88	305.88	305.88	-
Retained Earnings	493.1	327.82	993.46	575.48	103.91	98.34
Comprehensive Income & Other	-251.78	-251.78	-26.37	-26.37	-24.95	366.47
Total Common Equity	1,935	1,770	1,519	1,042	572.14	514.81
Minority Interest	-	-0	0	0	-0.93	-
Shareholders' Equity	1,935	1,770	1,519	1,042	571.21	514.81
Total Liabilities & Equity	3,763	3,456	2,627	2,278	1,558	1,601
Total Debt	960.03	1,151	591.48	638.99	670.21	903.21
Net Cash (Debt)	-316.63	-702.22	-243.44	-331.82	-648.02	-836.31
Net Cash Per Share	-0.80	-2.04	-0.88	-1.33	-8.98	-12.54
Filing Date Shares Outstanding	400	400	328.57	249.73	249.73	66.67
Total Common Shares Outstanding	400	400	328.57	249.73	249.73	66.67
Working Capital	526.69	497.98	428.98	126.89	-280.97	-300.37
Book Value Per Share	4.84	4.42	4.62	4.17	2.29	7.72
Tangible Book Value	1,894	1,736	1,494	1,030	570.91	514.54
Tangible Book Value Per Share	4.73	4.34	4.55	4.12	2.29	7.72
Land	-	124.07	108.09	94.16	64.95	64.95
Buildings	-	1,104	1,014	897.56	713.66	672.08
Machinery	-	609.53	548.56	448.73	415.39	378.1
Construction In Progress	-	81.94	68.6	93.44	82.16	75.3

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.